Susquehanna International Group’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$27.2M Sell
294,800
-156,100
-35% -$15.7M ﹤0.01% 1858
2025
Q4
$46.1M Buy
450,900
+134,200
+42% +$12M 0.01% 1431
2025
Q3
$19.8M Buy
316,700
+147,400
+87% +$8.02M ﹤0.01% 2221
2025
Q2
$8.81M Sell
169,300
-58,100
-26% -$2.59M ﹤0.01% 3009
2025
Q1
$9.69M Buy
227,400
+51,800
+29% +$2.23M ﹤0.01% 2575
2024
Q4
$5.36M Buy
175,600
+51,300
+41% +$1.44M ﹤0.01% 3478
2024
Q3
$2.85M Sell
124,300
-21,100
-15% -$597K ﹤0.01% 4639
2024
Q2
$4.2M Sell
145,400
-250,000
-63% -$5.82M ﹤0.01% 3727
2024
Q1
$8.16M Buy
395,400
+326,200
+471% +$6.99M ﹤0.01% 2916
2023
Q4
$1.87M Sell
69,200
-19,300
-22% -$506K ﹤0.01% 5505
2023
Q3
$2.62M Sell
88,500
-43,500
-33% -$1.53M ﹤0.01% 4624
2023
Q2
$4.73M Buy
132,000
+23,400
+22% +$672K ﹤0.01% 3637
2023
Q1
$2.55M Sell
108,600
-79,600
-42% -$2.27M ﹤0.01% 4647
2022
Q4
$5.12M Sell
188,200
-248,100
-57% -$11.4M ﹤0.01% 3191
2022
Q3
$23.5M Buy
436,300
+294,000
+207% +$15.1M 0.01% 1290
2022
Q2
$5.74M Buy
142,300
+96,600
+211% +$4.79M ﹤0.01% 2966
2022
Q1
$3.03M Sell
45,700
-18,200
-28% -$1.25M ﹤0.01% 4600
2021
Q4
$6.39M Sell
63,900
-8,000
-11% -$827K ﹤0.01% 3346
2021
Q3
$8.99M Sell
71,900
-24,200
-25% -$2.88M ﹤0.01% 3021
2021
Q2
$11.9M Sell
96,100
-19,100
-17% -$2.57M ﹤0.01% 2665
2021
Q1
$17.6M Sell
115,200
-46,900
-29% -$7.09M ﹤0.01% 2025
2020
Q4
$20.9M Sell
162,100
-72,900
-31% -$8.39M ﹤0.01% 1699
2020
Q3
$26.3M Sell
235,000
-36,700
-14% -$3.36M 0.01% 1261
2020
Q2
$22M Buy
271,700
+106,000
+64% +$8.54M 0.01% 1349
2020
Q1
$11.5M Sell
165,700
-198,200
-54% -$15.2M ﹤0.01% 1596
2019
Q4
$28.4M Buy
363,900
+61,200
+20% +$4.41M 0.01% 1147
2019
Q3
$19.3M Buy
302,700
+155,500
+106% +$13.7M 0.01% 1352
2019
Q2
$12.7M Sell
147,200
-40,500
-22% -$3.09M ﹤0.01% 1662
2019
Q1
$14.4M Buy
+187,700
New +$10.4M 0.01% 1440

Other funds holding GH

Susquehanna International Group's GH Position: Q1 2026 in Review

Susquehanna International Group increased its Guardant Health (GH) stake by 2,199% in Q1 2026, buying an estimated $7.3M and bringing the position to 75,989 shares worth $7.02M. The position accounts for ﹤0.01% of the portfolio, ranked #3657.

Susquehanna International Group first reported a position in GH in Q1 2019 and has held it in 27 quarters since. The position peaked at $15.5M in Q2 2020. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • Susquehanna International Group held 75,989 shares of Guardant Health worth $7.02M as of Q1 2026.
  • Susquehanna International Group bought 72,683 Guardant Health shares in Q1 2026, an estimated $7.3M.
  • Guardant Health made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #3657 holding.
  • Susquehanna International Group first reported a position in Guardant Health in Q1 2019 and has held it in 27 quarters since.
  • Susquehanna International Group's Guardant Health position peaked at $15.5M in Q2 2020.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.